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1 Introduction
The present document contains the assessment of the health hazard of clopidol 
by the Committee on Updating of Occupational Exposure Limits, a committee of 
the Health Council of the Netherlands. The first draft of this document was 
prepared by MA Maclaine Pont, M.Sc. (Wageningen University and Research 
Centre, Wageningen, the Netherlands).
The evaluation of the toxicology of clopidol has been based on the review by 
the American Conference of Industrial Hygienists (ACG99). Where relevant, the 
original publications were reviewed and evaluated as will be indicated in the text. 
In addition, in May 2000, literature was searched in the databases Toxline, 
Medline, and Chemical Abstracts covering the periods 1981 until May 2000, 
1966 until May 2000, and 1937 until April 2000, respectively, and using the 
following key words: clopidol; methylchloropindol; 4-pyridinol, 3,5-dichloro-
2,6-dimethyl-; or 2971-90-6. The final literature search was carried out in 
Medline and Toxline in January 2003.
In April 2003, the President of the Health Council released a draft of the 
document for public review. The committee received no comments.
2  Identity
name : clopidol
synonyms : 4-pyridinol, 3,5-dichloro-2,6-dimethyl-; methylchloropindol; 
meticlorpindol; clopindol
molecular formula : C7H7Cl2NO
structural formula :
CAS number : 2971-90-6
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3 Physical and chemical properties 
Data from ACG99, Bud96, http://esc.syrres.com.
Clopidol is a white crystalline powder (ACG99).
4 Uses
Clopidol is used as a coccidiostatic agent in poultry (ACG99).
5 Biotransformation and kinetics
After single or multiple oral doses of 16 mg/kg bw of 14C-clopidol to rabbits, the 
compound was rapidly absorbed and excreted via the urine for 90% or more 
within 24 hours after (final) dosing. Following repeated daily oral doses, no 
accumulation of radioactivity occurred in the tissues and no radioactivity was 
detected in the expired air. In the urine, 47% of the radioactivity was from 
unchanged clopidol, 32% from a hydroxylated product, and 20% probably from 
the O-glucuronide of the hydroxylated product. Thirty-two hours after the last of 
5 daily doses, no radioactivity was detected in the tissues or plasma of the 
rabbits. No half-life time was calculated (Cam75).
After a single oral dose of 50 mg 36Cl-clopidol to rats, about 10% of the 
radioactivity was still in the stomach 4 hours later. The urine and faeces excreted 
in those 4 hours did not contain any significant amount of radioactivity. Apart 
from the stomach, large quantities of radioactivity were found in decreasing 
order in the plasma, kidneys, whole blood, liver, lungs, and heart. Twenty-four 
hours after dosing, 60-65% and 35-40% of the radioactivity were found in the 
urine and faeces, respectively; at a dose of 10 mg/kg bw, these figures were about 
molecular weight : 192.04
boiling point : not available
melting point : >320oC
flash point : not available
vapour pressure : not available
solubility in water : insoluble 
log Poctanol/water : 2.71 (estimated)
conversion factors : not applicable
079-5 Clopidol
75-80% and 20-25%, respectively. The biological half-life of disappearance from 
rat tissues was in the order of 10 hours after dosing 50 mg/kg bw. There did not 
appear any significant accumulation of the radioactive compound in any of the 
tissues (Smi69b).
Clopidol did not accumulate in fat of cattle: after feeding with food 
containing 500 mg clopidol/kg, the concentration clopidol in fat after 28 days 
was 0.2-0.9 mg/kg (Ken80). Seven days after feeding chickens with 125 mg 36Cl-
clopidol/kg food, the amount of radioactivity in liver, plasma, and muscles was 
1-4 x 10-6 that of the original amount (0.01-0.04 ppm). No samples were taken at 
earlier time points; no half-life times were calculated (Smi69a).
6 Effects and mechanism of action
Human data
The committee did not find data on effects in humans due to exposure to 
clopidol.
Animal data
The committee did not find data on the potential irritation and sensitisation of 
clopidol.
An oral LD50 of 18,000 mg/kg bw has been reported in rats (Pli70; only abstract 
available). According to unpublished information, LD50 values were greater than 
8000 mg/kg bw for rats, rabbits, and guinea pigs (ACG99). 
Citing unpublished studies, it was stated that no adverse effects on growth, 
appearance, mortality, terminal haematological and clinical chemical 
examinations, final body and organ weights, gross and microscopic examinations 
of major organs, and tumour incidence were seen in rats fed 15 mg/kg bw /day, 
for 2 years. Also in dogs fed 5 mg/kg bw/day, for 2 years, there were no adverse 
effects (no more details presented) (ACG99).
Clopidol was well tolerated at 500 mg/kg food by lambs, and no toxic effects 
were observed in doses of 900 and 1800 mg/kg food. The length of the study was 
not given. A significant increase in leukocytes and lymphocytes was observed in 
all doses compared with controls. No significant changes were observed in the 
blood proteins, serum transaminases, liver, spleen, or kidneys (Sev72; only 
abstract available).
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Mutagenicity and genotoxicity
In vitro, clopidol did not induce gene mutations when tested with and without 
induced rat liver metabolic activation in S. typhimurium strains TA98, TA100, 
TA1535, TA1537, TA1538, and E. coli strain WP2 hcr at concentrations up to 
5000 µg/plate (Oht80). Clopidol produced negative results in a differential 
killing-rec assay using B. subtilis strains H17 (rec+) and M45 (rec-), an indicator 
test for DNA damage (Oht80).
The committee did not find data from mutagenicity or genotoxicity tests in 
mammalian cell systems.
Results from in vivo genotoxicity studies were published in Chinese and 
available from a very brief English abstract without presenting more data than 
are following below. In what is probably a dominant lethal assay, male mice were 
dosed daily with 100 mg clopidol/kg bw for 5 consecutive days and then mated 
with 6 groups of females serially for 6 weeks. In the third group of females, the 
number of living embryos for each female was lower (10.7) and the number of 
dead embryos significantly higher (1.2) when compared with controls (12.2 and 
0.044, respectively). Its 'mutagenic index' was significantly increased (10.1 vs. 
3.4). Further findings were increases in the frequence of micronucleated 
polychromatic erythrocytes (6.5% vs. 2.6%) in fetal mice liver 18 hours after 
treatment with a dose of 160 mg/kg clopidol, in polyploids (3% vs. 0.4%) and 
sperm abnormalities (5.34% vs. 3.28%) after a dose of 50 mg/kg bw, and in the 
number of sister chromatid exchanges per cell (4.27, 5.23, and 5.96, respectively, 
vs. 2.88) at doses of 10, 30, and 160 mg/kg bw, respectively (Bao92).
The committee concluded that clopidol may have mutagenic activity, but this 
should be investigated further.
Reproduction toxicity
Results from (what is probably a) teratogenicity study were published in Chinese 
and available from a very brief English abstract without presenting more data 
than are following below. Groups of pregnant Wistar rats received oral doses of 
clopidol of 0, 4, 20, 100, and 200 mg/kg bw on gestational days 6 through 15. At 
200 mg/kg bw, maternal body weights were decreased. The two highest doses 
decreased the pregnancy rate (p<0.01)*. At 200 mg/kg bw, fetal effects including 
* The committee notes that since treatment was started with animals that were pregnant already for 6 days, treatment 
cannot have been the cause of decreased pregnancy rates (unless something else was meant by this term).   
079-7 Clopidol
decreased body weight and length (p<0.05) and extra ribs and delayed 
ossification of the sternum (in 15/16 fetuses) were reported. The percentage fetal 
malformations was higher than that in controls. At 100 mg/kg bw, a decreased 
average litter weight was found (Jia99).
Citing unpublished studies, it was stated that clopidol had not induced 
adverse effects on fertility, gestation, viability, lactation, or on teratogenicity in 
rats and rabbits (no more data/details presented) (ACG99).
The committee concluded that clopidol may have effects on the development 
of offspring of rats, but this should be investigated further.
7 Existing guidelines
The current administrative occupational exposure limit (MAC) for clopidol in 
the Netherlands is 10 mg/m3, 8-hour TWA.
Existing occupational exposure limits for clopidol in some European 
countries and in the USA are summarised in the annex.
8 Assessment of health hazard
The committee did not find data on the toxicokinetics of clopidol following 
dermal or inhalation exposure. After oral intake, clopidol was absorbed and 
excreted rapidly. In rabbits, 90% or more of single or repeated radiolabelled 
doses of 16 mg/kg bw were excreted in the urine within 24 hours after dosing, a 
hydroxylated product and its O-glucuronide accounting for almost half of the 
radioactivity. In rats, orally given 10 or 50 mg/kg, about 65 and 80%, 
respectively, of the radioactivity administered was excreted in the urine, the 
remainder in the faeces.
The committee did not find data on the toxic effects of clopidol in humans.
Experimental animal data are limited to poorly reported information on 
systemic effects (including reproduction toxicity) following oral exposure. LD50 
values for rats, rabbits, and guinea pigs were greater than 8000 mg/kg bw. No 
effects were observed in rats and dogs fed daily doses of 15 or 5 mg/kg bw, 
respectively, for 2 years; in rats, there was no increase in tumour incidences. No 
effects on reproduction were reported in rats and rabbits given doses unknown to 
the committee in one study, but in another rat study, administration of doses of 
100 or 200 mg/kg bw during organogenesis caused decreased fetal weights and 
decreased fetal weights and sizes, increased incidence of fetal malformations, 
and decreased maternal body weights, respectively.
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Clopidol did not induce mutations or DNA damage in bacteria. In vivo, 
positive results were found for several endpoints in one poorly reported study.
The committee considers the database on clopidol too poor to justify 
recommendation of a health-based occupational exposure limit.
The committee concludes that there is insufficient information to comment on 
the level of the present MAC value.
Recommendations for research
The committee recommends to further investigate the mutagenicity/genotoxicity 
and reproduction toxicity of clopidol.
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Annex
Occupational exposure limits for clopidol in various countries.
country 
- organisation
occupational
exposure limit
time-weighted
average
type of
exposure limit
notea referenceb
ppm mg/m3
the Netherlands 
- Ministry of Social Affairs and 
Employment
- 10 8 h administrative SZW03
Germany
- AGS
- DFG MAK-Kommission
-
-
-
-
TRG00
DFG02
Great Britain
- HSE - - HSE02
Sweden - - Swe00
Denmark - 10 8 h Arb02
USA
- ACGIH
- OSHA
- NIOSH
-
-
-
-
10
15d ; 5e
10d; 5e
20e
8 h
8 h
10 h
15 min
TLV
PEL
REL
A4c ACG03b
ACG03a
ACG03a
European Union
- SCOEL - - EC03
a S = skin notation, which means that skin absorption may contribute considerably to body burden; sens = substance can 
cause sensitisation.
b Reference to the most recent official publication of occupational exposure limits.
c Classified in carcinogenicity category A4, i.e., not classifiable as a human carcinogen: agents which cause concern that 
they could be carcinogenic for humans but which cannot be assessed conclusively because of a lack of data. In vitro or 
animal studies do not provide indications of carcinogenicity which are sufficient to classify the agent into one of the other 
categories.  
d Total dust.
e Respirable fraction.
